Hepatitis Monthly

Published by: Kowsar

Estimation of Hepatitis A Virus Infection Prevalence Among Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Pooled Analysis

Mehdi Safiabadi 1 , 2 , 3 , Mohammad Saeid Rezaee-Zavareh 1 , 2 , 3 and Seyed Moayed Alavian 2 , 3 , *
Authors Information
1 Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, IR Iran
3 Middle East Liver Disease (MELD) Center, Tehran, IR Iran
Article information
  • Hepatitis Monthly: February 01, 2017, 17 (2); e44695
  • Published Online: January 14, 2017
  • Article Type: Review Article
  • Received: December 11, 2016
  • Accepted: January 7, 2017
  • DOI: 10.5812/hepatmon.44695

To Cite: Safiabadi M, Rezaee-Zavareh M S, Moayed Alavian S. Estimation of Hepatitis A Virus Infection Prevalence Among Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Pooled Analysis, Hepat Mon. 2017 ; 17(2):e44695. doi: 10.5812/hepatmon.44695.

Copyright © 2017, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Discussion
  • 1. Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Hepatitis A: Epidemiology and prevention in developing countries. World J Hepatol. 2012; 4(3): 68-73[DOI][PubMed]
  • 2. Rezaee-Zavareh MS, Karimi-Sari H, Dolatimehr F, Alavian SM. Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers. Hepat Mon. 2015; 15(12): 35238[DOI][PubMed]
  • 3. Shapiro CN, Margolis HS. Worldwide epidemiology of hepatitis A virus infection. J Hepatol. 1993; 18 Suppl 2: 11-4[PubMed]
  • 4. Wasley A, Fiore A, Bell BP. Hepatitis A in the era of vaccination. Epidemiol Rev. 2006; 28: 101-11[DOI][PubMed]
  • 5. Keeffe EB. Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases. Trans Am Clin Climatol Assoc. 2006; 117: 227-37[PubMed]
  • 6. Kanyenda TJ, Abdullahi LH, Hussey GD, Kagina BM. Epidemiology of hepatitis A virus in Africa among persons aged 1-10 years: a systematic review protocol. Syst Rev. 2015; 4: 129[DOI][PubMed]
  • 7. Tufenkeji H. Hepatitis A shifting epidemiology in the Middle East and Africa. Vaccine. 2000; 18 Suppl 1: 65-7[PubMed]
  • 8. Jamali R. Epidemiologic studies on viral hepatitis: A short review. Thrita. 2014; 3(1): 15376[DOI]
  • 9. Alavian SM, Rezaee-Zavareh MS. The Middle East and hepatitis C virus infection: does it need special attention? Lancet Infect Dis. 2016; 16(9): 1006-7[DOI][PubMed]
  • 10. The World Bank. Middle East and North Africa.
  • 11. Mahboobi N, Alavian SM. Hepatitis a in the eastern mediterranean region: A review on the prevalence. Scimetr. 2014; 2(1): 14613
  • 12. Farajzadegan Z, Hoseini SG, Kelishadi R, Jamshidi F, Nokhodian Z, Noori R, et al. Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran. J Res Med Sci. 2014; 19-63[PubMed]
  • 13. Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma Group . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4): 264-9[PubMed]
  • 14. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015; 386(10003): 1546-55[DOI][PubMed]
  • 15. Hepatitis A vaccines. Wkly Epidemiol Rec. 2000; 75(5): 38-44[PubMed]
  • 16. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010; 28(41): 6653-7[DOI][PubMed]
  • 17. Malik MA, Azam EM, Saboor A. Water quality status of upper kpk and northern areas of pakistan. 2010;
  • 18. Ahmad T, Anjum S, Sadaf Zaidi NU, Ali A, Waqas M, Afzal MS, et al. Frequency of hepatitis E and Hepatitis A virus in water sample collected from Faisalabad, Pakistan. Ann Agric Environ Med. 2015; 22(4): 661-4[DOI][PubMed]
  • 19. Hadjipanayis A, Hadjichristodoulou C, Kallias M, Sava K, Petsa A, Demetriadou K, et al. Prevalence of antibodies to hepatitis A among children and adolescents in Larnaca area, Cyprus. Eur J Epidemiol. 1999; 15(10): 903-5[PubMed]
  • 20. Potamides E, Koufoudakis L, Koumas M, Gogakis Z, Mavromoustakis C. Prevalence of hepatitis A, B and C markers in greek and cypriot soldiers. Iatriki Kypros. 1994; 12(2): 17-8
  • 21. Weiland O, Berg JV, Back E, Lundbergh P. Immunoglobulin prophylaxis against hepatitis A among Swedish UN soldiers in an endemic region. Infection. 1979; 7(5): 223-5[PubMed]
  • 22. Izadi M, Esfahani AA, Hassannia H, Jonaidi Jafari N, Rahmati Najarkolaei F, Rezaee-Zavareh MS. Seroprevalence of hepatitis A virus among Iranian soldiers. Gastroenterol Hepatol Bed Bench. 2016; 9(2): 100-4[PubMed]
  • 23. Hesamizadeh K, Sharafi H, Keyvani H, Alavian SM, Najafi-Tireh Shabankareh A, Sharifi Olyaie R, et al. Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran. Hepat Mon. 2016; 16(1): 32215[DOI][PubMed]
  • 24. WHO position paper on hepatitis A vaccines - June 2012. Wkly Epidemiol Rec. 2012; 87(28/29): 261-76[PubMed]
  • 25. Fangcheng Z, Xuanyi W, Mingding C, Liming J, Jie W, Qi J, et al. Era of vaccination heralds a decline in incidence of hepatitis A in high-risk groups in China. Hepat Mon. 2012; 12(2): 100-5[DOI][PubMed]
  • 26. Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA. 2005; 294(2): 202-10[DOI][PubMed]
  • 27. Wasley A, Samandari T, Bell BP. Incidence of hepatitis A in the United States in the era of vaccination. JAMA. 2005; 294(2): 194-201[DOI][PubMed]
  • 28. Hanna JN, Hills SL, Humphreys JL. Impact of hepatitis A vaccination of Indigenous children on notifications of hepatitis A in north Queensland. Med J Aust. 2004; 181(9): 482-5[PubMed]
  • 29. Khuroo MS. Viral hepatitis in international travellers: risks and prevention. Int J Antimicrob Agents. 2003; 21(2): 143-52[DOI][PubMed]
  • 30. Ghasemian R, Babamahmoodi F, Ahangarkani F. Hepatitis A Is a Health Hazard for Iranian Pilgrims Who Go to Holly Karbala: A Preliminary Report. Hepat Mon. 2016; 16(6): 38138[DOI][PubMed]
  • 31. Salmon-Rousseau A, Piednoir E, Cattoir V, de La Blanchardiere A. Hajj-associated infections. Med Mal Infect. 2016; 46(7): 346-54[DOI][PubMed]
  • 32. Rafiq SM, Rashid H, Haworth E, Booy R. Hazards of hepatitis at the Hajj. Travel Med Infect Dis. 2009; 7(4): 239-46[DOI][PubMed]
  • 33. Mohd Hanafiah K, Jacobsen KH, Wiersma ST. Challenges to mapping the health risk of hepatitis A virus infection. Int J Health Geogr. 2011; 10: 57[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments